Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Longholder99on Feb 15, 2024 7:46pm
207 Views
Post# 35883210

RE:Volume lately

RE:Volume latelyCamphikefish I think it's mostly about the company being relatively unknown and still a pre BTD micro cap.  Retailers who have done their research and have bought in are pretty much as deep as they dare to be.  Not selling....but not buying either. I'm probably known as a huge pumper on here and I still buy a few K here and there.... but it's always with a bit of concern for how long this has taken and I cringe with these PPs.  Institutional buyers won't touch a bio micro cap pre BTD and probably will wait until TLT is on the NASDAC before taking a position.  Big Pharm probably doesn't care what the SP is...they won't do anything until after BTD because this tech is brand new and unproven until the FDA says otherwise.  If the company gets derisked with BTD or whatever it takes.  Pharm will knock the door down and buy the place out and not care what the dollars are. Just my uneducated 2c.  
<< Previous
Bullboard Posts
Next >>